USPTO reveals 2013 fee changes

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

USPTO reveals 2013 fee changes

The USPTO has published new fees, most of which come into force on March 19

The changes will see reductions to the basic filing fee for utility patents (down to $280 from $380 for large entities) and design patents (reduced from $250 to $180).

Issue fees will be reduced and the $300 publication fee will be abolished in January 2014.

But maintenance fees are being increased, by between 26% and 56%.

There are also changes to claim fees, RCE fees, appeals, ex parte re-examination and inter partes reviews.

The fee changes result from the America Invents Act, which requires the USPTO to recover sufficient fees to cover its costs.

The agency proposed fee rules in September last year, and has reduced some fees in response to feedback received since then.

There are discounts for small and micro entities of up to 75% on many fees.

The full list of new fees is available on the USPTO website. Dennis Crouch on Patently O has summarised the major changes.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article